(Q53279945)

English

Hepatic Arterial Infusion Therapy with a Fine Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

scientific article published on August 5, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20688778

Hepatic Arterial Infusion Therapy with a Fine Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis (English)

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Masaaki Kondo

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20688778

Manabu Morimoto

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20688778

Kazushi Numata

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20688778

Akito Nozaki

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20688778

Katsuaki Tanaka

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20688778

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20688778

17 June 2024

publication date

5 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20688778

full work available at URL

https://academic.oup.com/jjco/article-pdf/41/1/69/5111529/hyq145.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688778

17 June 2024

http://jjco.oxfordjournals.org/cgi/content/abstract/41/1/69

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688778

17 June 2024

http://academic.oup.com/jjco/article-pdf/41/1/69/5111529/hyq145.pdf

Portable Document Format

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

Japanese Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20688778

41

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20688778

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20688778

69-75

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20688778

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ145

21 January 2018

Transcatheter oily chemoembolization of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ145

21 January 2018

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ145

21 January 2018

Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ145

21 January 2018

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ145

21 January 2018

Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ145

21 January 2018

Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ145

21 January 2018

Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ145

21 January 2018

Demonstration of Growing Casts of Hepatocellular Carcinoma in the Portal Vein by Celiac Angiography: The Thread and Streaks Sign

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ145

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ145

21 January 2018

Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ145

21 January 2018

Current management strategy of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ145

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ145

21 January 2018

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ145

21 January 2018

Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: A randomized phase III trial

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ145

21 January 2018

Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ145

21 January 2018

Global cancer statistics, 2002

1

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

2

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer

8

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

Japanese Journal of Clinical Oncology

11

23

105

author name string

Fujii

publication date

1993

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy

12

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization

13

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases

14

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study

15

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis

16

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma.

19

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

Hepato-Gastroenterology

20

50

809

author name string

Maeda

publication date

2003

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge

22

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

Radiotherapy: effective treatment at low cost!

28

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin

29

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

Remission and survival following monthly intraarterial cisplatinum in nonresectable hepatoma

30

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

35

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion

36

1 reference

10.1093/JJCO/HYQ145

https://api.crossref.org/works/10.1093/JJCO/HYQ145

17 June 2024

Identifiers

10.1093/JJCO/HYQ145

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20688778

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/20688778

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53279945&oldid=2182158953"